PATH
Menu

Filter browse results

Total results with these characteristics: 41

Subject: Vaccines and immunization > Human papillomavirus (HPV)

Page 2 of 3
Strategic Planning and Situation Assessment for Cervical Cancer Prevention: Practical Experience From PATH

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It aims to help decision-makers and program planners focus on key “big picture” questions about cervical cancer prioritization and on opportunities and challenges for improved cancer prevention, including vaccination of girls and precancer screening and treatment of adult women.

Publication date: 2011

Region: Global

Evaluating HPV Vaccine Delivery Strategies in Vietnam

This report is a synthesis of the project Evaluating HPV Vaccine Delivery Strategies in Vietnam, which aimed to identify appropriate strategies for human papillomavirus (HPV) vaccine delivery in different geographic and socioeconomic conditions. The report summarizes results of both the implementation and research aspects of the project. The document is available as one large file or as four smaller files for easier downloading.

Publication date: December 2010

Region: Asia

HPV Vaccination in Latin America: Lessons Learned From a Pilot Program in Peru

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: December 2010

Region: Global

Part of series: HPV vaccination project lessons learned reports

Monitoring Ambient and Cold Chain Temperatures During Delivery of Human Papillomavirus Vaccine in Vietnam and Uganda: Summary Report

As part of project Optimize, a five-year human papillomavirus (HPV) vaccine demonstration project is under way in Vietnam, Uganda, India, and Peru to generate evidence for government decision-making about successful vaccine delivery strategies to provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for storage and transport in a controlled temperature chain at temperatures higher than the standard 2° to 8°C cold chain storage.

Publication date: September 2010

Region: Global

Breakeven Analysis for Various Human Papillomavirus Vaccine Presentations in Vietnam and Uganda

The study highlighted in this project Optimize report uses a breakeven cost analysis to compare potential prices, wastage rates, and cold chain requirements for various human papillomavirus (HPV) vaccine presentations.

Publication date: August 2010

Region: Global

Cold Chain Temperature Monitoring in Vietnam: Monitoring Ambient and Cold Chain Temperatures During Delivery of Human Papillomavirus Vaccine

Human papillomavirus (HPV) vaccine is intended to prevent cervical cancer. As part of project Optimize, a two-year HPV vaccine demonstration project is being conducted to demonstrate how existing delivery systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for out-of-the-cold-chain use given its characteristics of high heat stability and freeze sensitivity.

Author: Robertson J, Vu H, Le N, et al.

Publication date: July 2010

Region: Global

Progress in Preventing Cervical Cancer: Updated Evidence on Vaccination and Screening (Outlook, vol. 27, no. 2)

This issue of Outlook provides an update on opportunities for preventing cervical cancer through vaccination and screening. It summarizes recent evidence on the safety and efficacy of human papillomavirus vaccines as well as successful approaches for screening and treatment in low-resource areas. Other topics include cost-effectiveness, communication and training, and implications for policy and programs.

Author: Murray M

Publication date: May 2010

Region: Global

Part of series: Outlook

Saving Lives With Multipurpose Prevention Technologies: Turning Ideas Into Solutions for Sexual and Reproductive Health

This publication describes the public health potential of multipurpose prevention technologies -- that is, technologies that prevent unintended pregnancy; sexually transmitted infections, including HIV; and/or other reproductive tract infections. While a few such technologies exist, greater collaboration and resources are needed to accelerate research and development efforts and bring new technologies into widespread use.

Author: Holt BY, Kilbourne-Brook M, Cohen J, Burns M

Publication date: May 2010

Region: Global

Results From a Survey of Immunization Stakeholders in Vietnam Regarding the Presentation, Packaging, and Distribution of Human Papillomavirus Vaccines

The purpose of this project Optimize survey was to obtain input from stakeholders within the Expanded Programme on Immunization in Vietnam about issues and perceptions related to the storage, distribution, and delivery of the current and potential options for human papillomavirus vaccine presentation and packaging.

Publication date: December 2009

Region: Asia

Kill or Cure? The Real Lady Killer

This film in the BBC World’s Kill or Cure? series uncovers the challenges of preventing and treating cervical cancer in Africa and highlights exciting new opportunities for dramatically reducing the toll of disease. The BBC crew follows Sarah Nyombi—Ugandan member of parliament, trained midwife, and women's health advocate—as she explores the landscape of cervical cancer. The film is available in two versions: 25 minutes and 12 minutes.

Publication date: July 2009

Region: Global

Part of series: Kill or Cure? videos

Shaping a Strategy to Introduce HPV Vaccines in India

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in India. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Asia

Shaping a Strategy to Introduce HPV Vaccines in Peru

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Peru. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Latin America

Shaping a Strategy to Introduce HPV Vaccines in Uganda

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Uganda. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Africa

Shaping a Strategy to Introduce HPV Vaccines in Vietnam

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in Vietnam. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Asia

HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. Country decision-makers will need to weigh the value of HPV vaccines against other national health priorities, against other vaccines entering the market, and, for some countries, against expanding coverage of existing vaccines. With these cost and financing obstacles resolved, developing countries would be able to build robust programs to immunize adolescents and thus dramatically reduce the incidence of cervical cancer.

Publication date: December 2007

Region: Global

Making Cervical Cancer Vaccines Widely Available in Developing Countries: Cost and Financing Issues

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. This brief summarizes the main findings of the longer research publication, HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues.

Publication date: December 2007

Region: Global

Directions in Global Health (Volume 4, Issue 1)

This special issue of Directions in Global Health highlights PATH's vaccine partnership efforts: PATH Malaria Vaccine Initiative (MVI), pneumococcal vaccine development project, Meningitis Vaccine Project, cervical cancer vaccine project, and Rotavirus Vaccine Program. The issue also features a case study of the vaccine vial monitor.

Author: PATH

Publication date: May 2007

Region: Global

Part of series: Directions in Global Health

Current and Future HPV Vaccines: Promise and Challenges

This 72-page document offers an in-depth look at vaccines against human papillomavirus (HPV), both currently available vaccines and those in development, including therapeutic vaccines. The document includes an examination of programmatic issues relevant to developing countries.

Author: Kols A

Publication date: 2006

Region: Global

Introducing HPV Vaccines in Developing Countries: Overcoming the Challenges

This fact sheet focuses on the challenges of introducing HPV vaccines into developing countries.

Author: Herdman C; Demspey M

Publication date: 2005

Region: Global

Status Report on Human Papillomavirus Vaccines

Status report on HPV vaccines

Author: Herdman C

Publication date: 2005

Region: Global

Page 2 of 3